• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性输尿管梗阻患者的预后标志物。

Prognostic marker for patients with malignant ureter obstruction.

机构信息

Department of Urology, Tokyo Metropolitan Tama Medical Center, 2-9-2 Musashi-dai, Fuchu, Tokyo, Japan.

出版信息

Clin Genitourin Cancer. 2013 Sep;11(3):353-6. doi: 10.1016/j.clgc.2013.04.030. Epub 2013 Jun 17.

DOI:10.1016/j.clgc.2013.04.030
PMID:23787166
Abstract

PURPOSE

To investigate the relationship between overall survival (OS) and prognostic risk factors for patients with malignant ureteral obstruction.

PATIENTS AND METHODS

We retrospectively evaluated 214 patients who had received a nephrostomy for ureteral obstruction because of malignancy. Univariate and multivariate Cox regression models addressed OS.

RESULTS

The median OS was 6.4 months. The OS at 1, 3, 6, and 12 months were 89.5%, 72.4%, 53.0%, and 26.5%, respectively. Using univariate Cox regression analysis, serum levels of creatinine (P = .0131), albumin (P < .0001), sodium (P < .0001), potassium (P = .0141), corrected calcium (P = .0167), C-reactive protein (P < .0001), white blood cell count (P = .0246), and the number of events related to malignant dissemination (P < .0001) were associated with OS. Using multivariate Cox regression analysis, serum levels of albumin (P = .0147), sodium (P = .0046), C-reactive protein (P < .0001), and the number of events related to malignant dissemination (P = .0002) were independent predictors of OS.

CONCLUSION

Low serum levels of albumin and sodium and the number of events related to malignant dissemination before PCN were independent factors associated with a poor prognosis. High serum C-reactive protein level was also associated with a poor prognosis using multivariate analysis.

摘要

目的

探讨伴有恶性输尿管梗阻患者的总生存期(OS)与预后危险因素之间的关系。

患者与方法

我们回顾性评估了 214 例因恶性肿瘤而行输尿管梗阻肾造口术的患者。单因素和多因素 Cox 回归模型分析了 OS。

结果

中位 OS 为 6.4 个月。1、3、6 和 12 个月的 OS 分别为 89.5%、72.4%、53.0%和 26.5%。使用单因素 Cox 回归分析,血清肌酐水平(P=0.0131)、白蛋白(P<0.0001)、钠(P<0.0001)、钾(P=0.0141)、校正钙(P=0.0167)、C 反应蛋白(P<0.0001)、白细胞计数(P=0.0246)和与恶性播散相关的事件数(P<0.0001)与 OS 相关。使用多因素 Cox 回归分析,白蛋白(P=0.0147)、钠(P=0.0046)、C 反应蛋白(P<0.0001)和与恶性播散相关的事件数(P=0.0002)是 OS 的独立预测因素。

结论

PCN 前血清白蛋白和钠水平较低以及与恶性播散相关的事件数是预后不良的独立因素。使用多变量分析,高血清 C 反应蛋白水平也与预后不良相关。

相似文献

1
Prognostic marker for patients with malignant ureter obstruction.恶性输尿管梗阻患者的预后标志物。
Clin Genitourin Cancer. 2013 Sep;11(3):353-6. doi: 10.1016/j.clgc.2013.04.030. Epub 2013 Jun 17.
2
Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.预测输尿管梗阻姑息性尿流改道术后生存情况的预后模型:140例分析
J Urol. 2008 Aug;180(2):618-21; discussion 621. doi: 10.1016/j.juro.2008.04.011. Epub 2008 Jun 12.
3
Prognostic factors in malignant ureteric obstruction.恶性输尿管梗阻的预后因素。
BJU Int. 2009 Oct;104(7):938-41. doi: 10.1111/j.1464-410X.2009.08492.x. Epub 2009 Mar 26.
4
Clinical Factors Associated With a Short Survival Time After Percutaneous Nephrostomy for Ureteric Obstruction in Cancer Patients: An Updated Model.癌症患者输尿管梗阻经皮肾造瘘术后生存时间短的相关临床因素:一个更新的模型
J Pain Symptom Manage. 2016 Feb;51(2):255-61. doi: 10.1016/j.jpainsymman.2015.09.009. Epub 2015 Oct 20.
5
Malignant ureteral obstruction: outcomes after intervention. Have things changed?恶性输尿管梗阻:干预后的结果。情况有变化吗?
J Urol. 2007 Jul;178(1):178-83; discussion 183. doi: 10.1016/j.juro.2007.03.026. Epub 2007 May 17.
6
A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.恶性输尿管梗阻姑息性尿流改道术后生存的预后模型:一项对208例患者的前瞻性研究
BJU Int. 2016 Feb;117(2):266-71. doi: 10.1111/bju.12963. Epub 2015 May 24.
7
Prognostic factors for overall survival in malignant ureteral obstruction.恶性输尿管梗阻总生存的预后因素。
Can J Urol. 2022 Jun;29(3):11162-11169.
8
Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?经皮肾造瘘术与留置输尿管支架在晚期恶性肿瘤所致输尿管外梗阻治疗中的比较:有差异吗?
Urology. 2004 Nov;64(5):895-9. doi: 10.1016/j.urology.2004.06.029.
9
Use of nephrostomy tubes in ureteric obstruction from incurable malignancy.肾造瘘管在无法治愈的恶性肿瘤所致输尿管梗阻中的应用。
Int J Clin Pract. 2003 Apr;57(3):180-1.
10
Tandem Ureteral Stents for Malignant Ureteral Obstruction.双 J 管在恶性输尿管梗阻中的应用。
J Endourol. 2020 Feb;34(2):222-226. doi: 10.1089/end.2019.0685.

引用本文的文献

1
Urinary Diversion Can Improve the Chance of Implementing New Therapeutic Lines in Patients with Malignant Ureteral Obstruction: A Multicenter Study.尿流改道可提高恶性输尿管梗阻患者实施新治疗方案的机会:一项多中心研究。
Curr Oncol. 2024 Nov 13;31(11):7107-7116. doi: 10.3390/curroncol31110523.
2
Malignant upper urinary tract obstruction in cancer patients: A systematic review.癌症患者恶性上尿路梗阻:一项系统综述。
BJUI Compass. 2024 Feb 27;5(5):405-416. doi: 10.1002/bco2.340. eCollection 2024 May.
3
Acute kidney injury due to bilateral malignant ureteral obstruction: Is there an optimal mode of drainage?
双侧恶性输尿管梗阻所致急性肾损伤:是否存在最佳引流方式?
World J Nephrol. 2022 Nov 25;11(6):146-163. doi: 10.5527/wjn.v11.i6.146.
4
A novel risk classification score for malignant ureteral obstruction: a multicenter prospective validation study.一种用于恶性输尿管梗阻的新型风险分类评分:一项多中心前瞻性验证研究。
Sci Rep. 2021 Feb 24;11(1):4455. doi: 10.1038/s41598-021-84054-7.
5
Malignant ureteric obstruction decompression: how much gain for how much pain? A narrative review.恶性输尿管梗阻减压:有多少获益,就有多少痛苦?一篇综述性评论。
J R Soc Med. 2018 Apr;111(4):125-135. doi: 10.1177/0141076818766725.
6
Stents for malignant ureteral obstruction.用于恶性输尿管梗阻的支架
Asian J Urol. 2016 Jul;3(3):142-149. doi: 10.1016/j.ajur.2016.04.002. Epub 2016 May 13.